Whole blood transcriptomics analysis of 24h-responses to bevacizumab/erlotinib in non-squamous non-small cell lung cancer: A multicenter phase II trial SAKK19/05

Journal of Clinical Oncology(2011)

引用 1|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要